The estimated Net Worth of Brian J Blaser is at least $14.9 Million dollars as of 23 May 2019. Brian Blaser owns over 450,062 units of Quanterix Corp stock worth over $7,010,340 and over the last 15 years Brian sold QTRX stock worth over $7,899,488.
Brian has made over 20 trades of the Quanterix Corp stock since 2011, according to the Form 4 filled with the SEC. Most recently Brian exercised 450,062 units of QTRX stock worth $17,295,883 on 23 May 2019.
The largest trade Brian's ever made was exercising 450,062 units of Quanterix Corp stock on 23 May 2019 worth over $17,295,883. On average, Brian trades about 14,961 units every 59 days since 2010. As of 23 May 2019 Brian still owns at least 580,807 units of Quanterix Corp stock.
You can see the complete history of Brian Blaser stock trades at the bottom of the page.
Brian's mailing address filed with the SEC is C/O QUANTERIX CORPORATION, 900 MIDDLESEX TURNPIKE, BILLERICA, MA, 01821.
Over the last 7 years, insiders at Quanterix Corp have traded over $25,118,881 worth of Quanterix Corp stock and bought 1,481,095 units worth $18,701,541 . The most active insiders traders include David R Walt, Paul M Meister und Keith Crandell. On average, Quanterix Corp executives and independent directors trade stock every 7 days with the average trade being worth of $100,483. The most recent stock trade was executed by Masoud Toloue on 13 August 2024, trading 19,000 units of QTRX stock currently worth $207,100.
quanterix offers an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. the single molecule array (simoa™) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more. quanterix is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at tufts university by dr. david walt, scientific founder of quanterix and illumina (nasdaq: ilmn).
Quanterix Corp executives and other stock owners filed with the SEC include: